SimcoDerm

Vitiligo Treatment

SimcoDerm

Vitiligo

Melanin determines the colour of our hair and skin. Vitiligo results when the cells that produce melanin are destroyed. This condition will cause a loss of skin pigmentation on your skin, and white patches will generally become larger over time. The skin on any part of your body can be affected by this disease, and here at Simcomed Health Ltd, we can provide you with the proper treatment.

There is no cure for vitiligo, but there are different treatment options we can discuss to help stop or slow down the process of depigmentation. It's also possible for some treatments to help return some colour to your skin. We will provide you with our professional recommendation regarding which treatment would be most effective.

We can prescribe corticosteroid creams if vitiligo is in its early stages, which can sometimes help one's natural skin colour return. We can also discuss medications that will impact your immune system, as these can help with small areas, particularly on the neck and face. Light therapy is another option we can consider which would slow the progression of active vitiligo and sometimes even stop it altogether. The combination of psoralen and light therapy can also be effective in helping to return colour to white patches of skin. Psoralen will have to be taken by mouth, or it can be applied to the skin, after which the targeted area will be exposed to UVA light.

For widespread vitiligo, depigmentation may be the only option. However, this therapy is not often used, so it will only be considered if vitiligo has not responded to other treatments. A depigmenting agent will be applied to the unaffected areas of the skin, which will lighten your skin so that it matches any discoloured areas.

Also, Adults aged 18 years or older with a clinical diagnosis of non-segmental vitiligo (bilateral and symmetrical loss of skin pigment), may qualify to participate in a new clinical trial for vitiligo. 

Individuals must have a loss of skin pigment on the face and body, along with at least one active vitiligo lesion. Individuals must agree to discontinue all agents used to treat vitiligo from screening through the final safety follow-up visit. 

Participants will receive investigational topical medication (active study drug) or placebo, during the initial treatment period. In the extension period, all subjects will receive active study drug. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided. 

Study participation will last about 63 weeks and involve about 11 visits to the study centre.

We will discuss the risks and advantages of every treatment option and address your concerns so that you are aware of every detail. We genuinely care about our patients, and you can rely on our dermatologist for all of your skin treatment needs. We offer vitiligo treatment, hidradenitis suppurativa treatment, atopic dermatitis treatment and more, so contact us today if you are looking for a reputable skin doctor near Barrie.